Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2024-08-19 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
2024年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2024 Half-Year Special Report on the Deposit and Actual Use of Raised Funds" by Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the amount of funds raised through a public stock issuance, the timing of fund receipt, usage of the raised funds during the first half of 2024, management of the funds, and the status of idle funds invested in financial products. It includes detailed financial figures, bank account information, and investment project progress. The document is a comprehensive report on the use and management of capital raised from investors, specifically focusing on the half-year period ending June 30, 2024. This matches the characteristics of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital usage. It is not an announcement of a report publication, nor a full annual or interim financial report. Therefore, the appropriate classification is CAP.
2024-08-19 Chinese
第三届监事会第十七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the meeting date, attendance, and the approval of two agenda items: the 2024 semi-annual report and a special report on the use of raised funds. The document references the actual reports published separately on the Beijing Stock Exchange information disclosure platform, indicating this document itself is not the report but an announcement of the meeting resolutions approving those reports. The document length is short (1392 characters), and it does not contain substantive financial data or the reports themselves. Therefore, it fits best as a Regulatory Filing (RNS) since it is a formal announcement of meeting resolutions and approvals, not the reports themselves or voting results from a shareholder meeting.
2024-08-19 Chinese
关于出售控股子公司股权暨完成工商变更登记的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the sale of a controlling stake in a subsidiary and completion of related business registration changes. It includes detailed transaction information, financial data of the subsidiary, regulatory references about asset reorganization thresholds, and confirms that the transaction does not constitute a major asset reorganization or related party transaction. The document is a formal disclosure of a corporate transaction rather than a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion and analysis. It is not a report publication announcement since it contains substantive transaction details. The content fits the category of Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through disposal of subsidiary equity and related corporate actions.
2024-07-29 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of stock trading restrictions (解除限售公告) for certain shares of the company. It details the number of shares becoming tradable, the shareholders involved, and the reasons for lifting the restrictions. It does not contain financial statements, earnings data, or management discussion. It is a regulatory announcement about share status changes, specifically about stock unlocking and trading eligibility. This fits the category of Share Issue/Capital Change (SHA) as it relates to changes in share capital availability and trading status.
2024-07-01 Chinese
第三届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 19th meeting of the 3rd Board of Directors of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the meeting date, attendance, agenda items, and voting results. The content focuses on board decisions such as guarantees for subsidiaries and project delays, with no financial statements or detailed management analysis. It is not a full report but a formal disclosure of board meeting outcomes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear meeting and resolution details.
2024-06-20 Chinese
第三届监事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company regarding the approval of a proposal to extend the completion date of certain fundraising investment projects. It includes details about the meeting date, attendance, agenda, and voting results. There is no financial data or detailed report content, only a formal announcement of a board meeting decision. This fits the category of Board/Management Information (MANG), as it relates to internal governance decisions and board resolutions rather than a full report or financial disclosure.
2024-06-20 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.